Moolec Science S.A. cash flow to debt ratio of -9.90% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Moolec Science S.A.'s free cash flow has decreased 217.33% from $-9.49M last year to $-30.10M, signaling decreasing performance

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A. has negative EBITDA, making leverage ratio unreliable

Interest expense is not separately reported in Moolec Science S.A.'s latest filing, so interest coverage cannot be calculated.

Moolec Science S.A.'s profit margin was -129.99% last year and is -33.41% this year, signaling increasing performance

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Moolec Science S.A.'s return on equity of 376.84%, is higher than 15.00%, indicating good performance

Moolec Science S.A.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Moolec Science S.A. has insufficient public price history to evaluate earnings stability.

Moolec Science S.A. has negative free cash flow, indicating the company is burning cash rather than generating it

Moolec Science S.A. has negative free cash flow, indicating cash burn

Moolec Science S.A.'s yearly earnings has decreased 1.42K% since last year from $-7.31M to $-111.46M, signaling decreasing performance

Moolec Science S.A. has insufficient data to evaluate this check.

ROIC -5.35% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Moolec Science S.A. has insufficient revenue history to calculate 3-year revenue CAGR.

Moolec Science S.A. has insufficient public price history to evaluate revenue consistency.

Moolec Science S.A. has insufficient public price history to evaluate ROE consistency.

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Moolec Science S.A. has insufficient data to evaluate this check.

Moolec Science S.A. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Moolec Science S.A. has negative shareholder equity; price-to-book is not meaningful and the check fails

Moolec Science S.A. has a price-to-sales ratio of 0.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue